COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspectivehttps://www.shieldshealthsolutions.com/wp-content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
By Claudia S. Castro, PharmD, MS, BCOP, BCGP; and Amanda Manoogian, PharmD, BCOP The prevalence of individuals living with cancer continues to rise, largely because of an aging and growing…
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19https://www.shieldshealthsolutions.com/wp-content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
By Vinay Sawant, RPh, MPH, MBA; Ayse Hursid, PharmD; Osama Abdelghany, PharmD, MHA, BCOP; and Terri Sue Bukowski, PharmD, CSP The coronavirus disease 2019 (COVID-19) pandemic has resulted in rewriting…
Hospitals adapt real estate to fit new normal after COVID-19https://www.shieldshealthsolutions.com/wp-content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
Health systems are reassessing their real estate portfolios as they prepare for a post-COVID-19 environment that will likely feature more home-based care and remote working arrangements.
New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemiahttps://www.shieldshealthsolutions.com/wp-content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
Erin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Carehttps://www.shieldshealthsolutions.com/wp-content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
By Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp
Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.